J
Johnson & Johnson (JNJ)
NYQ – Real Time Price. Currency in USD
224.26
+2.83 (1.28%)
At close: May 12, 2026, 4:00 PM EDT
224.37
+0.11 (0.05%)
After-hours: May 12, 2026, 7:59 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NYQ – Real Time Price. Currency in USD
224.26
+2.83 (1.28%)
At close: May 12, 2026, 4:00 PM EDT
224.37
+0.11 (0.05%)
After-hours: May 12, 2026, 7:59 PM EDT
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
| Name | Position |
|---|---|
| Dr. John C. Reed M.D., Ph.D. | Executive Vice President of Innovative Medicine and R&D |
| Mr. Dirk Brinckman | Chief Compliance Officer |
| Mr. James Swanson | Executive VP & Chief Information Officer |
| Mr. Joaquin Duato | CEO & Chairman |
| Mr. Joseph James Wolk CPA | Executive VP & CFO |
| Mr. Robert J. Decker Jr. | Controller & Chief Accounting Officer |
| Mr. Timothy Schmid | Executive VP & Worldwide Chairman of MedTech |
| Ms. Elizabeth Forminard J.D. | Executive VP & Chief Legal Officer |
| Ms. Jennifer L. Taubert | Executive VP & Worldwide Chairman of Innovative Medicine |
| Ms. Kristen Blair Mulholland | Executive VP & Chief Human Resources Officer |
| Date | Type | Document |
|---|---|---|
| 2026-04-28 | 8-K | jnj-20260423.htm |
| 2026-04-22 | 10-Q | jnj-20260329.htm |
| 2026-04-14 | 8-K | jnj-20260414.htm |
| 2026-03-11 | DEFA14A | a2026jnjdefa14a-additional.htm |
| 2026-03-11 | ARS | jnj014992-ars.pdf |
| 2026-02-11 | S-3ASR | d80821ds3asr.htm |
| 2026-01-21 | 8-K | jnj-20260121.htm |
| 2025-10-22 | 10-Q | jnj-20250928.htm |
| 2025-10-14 | 8-K | jnj-20251014.htm |
| 2025-09-09 | 8-K | jnj-20250908.htm |